Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

We investigated the determinants of hepatic clearance functions in a rat model of liver cirrhosis induced by phenobarbital/CCl4. Aminopyrine N-demethylation (ABT), galactose elimination (GBT), and serum bile acids (SBA) were determined in vivo. The livers were then characterized hemodynamically: intrahepatic shunting (IHS) was determined by microspheres and sinusoidal capillarization by measuring the extravascular albumin space (EVA) by a multiple indicator dilution technique. The intrinsic clearance was determined by assaying the activity of the rate-limiting enzymes in vitro. Hepatocellular volume (HCV) was measured by morphometry. ABT and SBA, but not GBT, differentiated cirrhotic from normal liver. IHS ranged from normal to 10%; all cirrhotic livers showed evidence of sinusoidal capillarization (reduced EVA). The cirrhotic livers showed a bimodal distribution of HCV, HCV being decreased in 50% of the cirrhotic livers. Multivariate analysis showed EVA and portal flow to be the main determinants of microsomal (ABT) and cytosolic (GBT) clearance function; SBA, by contrast, were determined solely by IHS. We conclude that sinusoidal capillarization is the main determinant of hepatic clearance, while serum bile acids reflect intrahepatic shunting. These findings emphasize the importance of alterations of hepatic nutritional flow to explain reduced clearance function in cirrhosis of the liver.

[1]  N. Tygstrup.  Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution. , 1963, Acta physiologica Scandinavica.

[2]  R. Groszmann,et al.  Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technic. , 1972, The American journal of medicine.

[3]  T. Sauerbruch,et al.  Prognostic significance of serum bile acids in cirrhosis , 1986, Hepatology.

[4]  R. Groszmann,et al.  Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. , 1983, The American journal of physiology.

[5]  R. Branch,et al.  Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat. , 1979, Gastroenterology.

[6]  S. Keiding,et al.  Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver. , 1978, The Journal of pharmacology and experimental therapeutics.

[7]  J. Bircher,et al.  Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat. , 1976, The Journal of pharmacology and experimental therapeutics.

[8]  Kamada Takenobu,et al.  The levels of the mitochondrial and microsomal cytochromes in drinkers' livers , 1978 .

[9]  J. Saric,et al.  Congenital portacaval shunt in rats: Liver adaptation to lack of portal vein—a light and electron microscopic study , 1985, Hepatology.

[10]  A. Zimmermann,et al.  Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study. , 1987, Gastroenterology.

[11]  H. Poulsen,et al.  The capacity of urea-N synthesis as a quantitative measure of the liver mass in rats. , 1986, Journal of hepatology.

[12]  Richard H. Jones,et al.  Decreased uptake of taurocholate and ouabain by hepatocytes isolated from cirrhotic rat liver , 1987, Hepatology.

[13]  J. Villeneuve,et al.  Prognostic value of the aminopyrine breath test in cirrhotic patients , 1986, Hepatology.

[14]  F. Ingelfinger,et al.  Hepatic Circulation in Cirrhosis of the Liver , 1952, Circulation.

[15]  J. Villeneuve,et al.  Determinants of Drug Disposition in Patients with Cirrhosis , 2007, Hepatology.

[16]  J. Bircher,et al.  Aminopyrine demethylation measured by breath analysis in cirrhosis , 1976, Clinical pharmacology and therapeutics.

[17]  J. Lindskov.  The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis. , 2009, Acta medica Scandinavica.

[18]  T. Zysset,et al.  Altered liver function in diabetes: model experiments with aminopyrine in the rat. , 1987, The Journal of pharmacology and experimental therapeutics.

[19]  I. Makino,et al.  Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis. , 1984, Gastroenterology.

[20]  U. Klotz,et al.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man. , 1975, The Journal of clinical investigation.

[21]  L M Cruz-Orive,et al.  Sampling designs for stereology * , 1981, Journal of microscopy.

[22]  J. Boyer,et al.  Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. , 1978, Gastroenterology.

[23]  J. D. Shoop,et al.  Test for alcoholic cirrhosis by conversion of [14C]- or [13C]galactose to expired CO2. , 1976, Gastroenterology.

[24]  J. Reichen,et al.  The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: Correlation with morphometric measurement of hepatocyte mass , 1987, Hepatology.

[25]  L. Ranek,et al.  Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. , 1976, Gut.

[26]  D. Valla,et al.  Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive rat. , 1986, The Journal of laboratory and clinical medicine.

[27]  J. Laissue,et al.  Criteria for Assessment of Functional Impairment in Patients with Cirrhosis of the Liver * , 1973, European journal of clinical investigation.

[28]  C. Goresky,et al.  On the uptake of materials by the intact liver. The transport and net removal of galactose. , 1973, The Journal of clinical investigation.

[29]  J. Villeneuve,et al.  Assessment of liver microcirculation in human cirrhosis. , 1982, The Journal of clinical investigation.

[30]  G. W. Snedecor.  Statistical Methods , 1964 .

[31]  F. Ossenberg,et al.  Liver atrophy following portacaval shunt in normal rats —a morphometric study— , 1977, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[32]  K. Zierler,et al.  On the theory of the indicator-dilution method for measurement of blood flow and volume. , 1954, Journal of applied physiology.

[33]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[34]  R. Branch,et al.  Impaired drug metabolism in experimental cirrhosis in the rat. , 1978, Biochemical pharmacology.

[35]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .

[36]  M. Kutner,et al.  Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival? , 1983, Annals of surgery.

[37]  Y. Shin-Buehring,et al.  A simple assay for galactokinase using DEAE-cellulose column chromatography. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[38]  J. Schneider,et al.  The Aminopyrine Breath Test and Serum Bile Acids Reflect Histologic Severity in Chronic Hepatitis , 2007, Hepatology.

[39]  R. Groszmann,et al.  Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease. , 1972, The American journal of medicine.

[40]  S. Riegelman,et al.  An automated HPLC method for the assay of propranolol and its basic metabolites in plasma and urine. , 1982, Journal of chromatographic science.

[41]  D. Lebrec,et al.  Mechanisms for reduced hepatic clearance and elevated plasma levels of bile acids in cirrhosis. A study in patients with an end-to-side portacaval shunt. , 1981, Gastroenterology.

[42]  R. Groszmann,et al.  Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. , 1981, The American journal of physiology.

[43]  D. Pessayre,et al.  Mechanism for reduced drug clearance in patients with cirrhosis , 1978 .

[44]  G. Paumgartner,et al.  Increased serum bile acids in cirrhosis with normal transaminases. , 1982, Digestion.

[45]  F Varin,et al.  Hepatic microcirculation in the perfused cirrhotic rat liver. , 1985, The Journal of clinical investigation.

[46]  J. Bircher,et al.  The portacaval and splenocaval shunt in the normal rat. A morphometric and functional reevaluation. , 1985, Journal of hepatology.

[47]  F. Bazzoli,et al.  Diagnostic Effectiveness of Serum Bile Acids in Liver Diseases as Evaluated by Multivariate Statistical Methods , 2007, Hepatology.

[48]  J. Reichen,et al.  Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver. , 1986, The Journal of clinical investigation.

[49]  L. Powell,et al.  Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes , 1979, Clinical pharmacology and therapeutics.